| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2022 | Jul 21, 2022 | CytomX Therapeutics, Inc. | Chief Medical Officer | Sell | 90.0 | +9,398 | 41.77% | ✗ | $8K |
| Jul 27, 2017 | Jul 31, 2017 | NEOGENOMICS INC | Director | Buy | 95.0 | +20,000 | 106.48% | ✗ | $183.8K |
| Mar 3, 2016 | Mar 4, 2016 | NEOGENOMICS INC | Director | Buy | 95.0 | +10,000 | 641.03% | ✗ | $69K |